Global Drug and Alcohol Testing Market Size, Status and Forecast 2019-2025

2 Global Drug and Alcohol Testing Quarterly Market Size Analysis

• 2.1 Drug and Alcohol Testing Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug and Alcohol Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug and Alcohol Testing Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Drug and Alcohol Testing Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Drug and Alcohol Testing Headquarters and Area Served
• 3.3 Date of Key Players Enter into Drug and Alcohol Testing Market
• 3.4 Key Players Drug and Alcohol Testing Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug and Alcohol Testing Segments, By Type

• 4.1 Introduction
  • 1.4.1 Immunoassay Analyzers
  • 1.4.2 Chromatography
  • 1.4.3 Breath Analyzers
  • 1.4.4 Rapid Testing Devices
  • 1.4.5 Other
• 4.2 By Type, Global Drug and Alcohol Testing Market Size, 2019-2021

5 Impact of Covid-19 on Drug and Alcohol Testing Segments, By Application

• 5.1 Overview
  • 5.5.1 Urine, Breath
  • 5.5.2 Saliva
  • 5.5.3 Hair
  • 5.5.4 Blood
  • 5.5.5 Other
• 5.2 By Application, Global Drug and Alcohol Testing Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug and Alcohol Testing Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Quest Diagnostics
  • 7.1.1 Quest Diagnostics Business Overview
  • 7.1.2 Quest Diagnostics Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.1.3 Quest Diagnostics Drug and Alcohol Testing Product Introduction
  • 7.1.4 Quest Diagnostics Response to COVID-19 and Related Developments
• 7.2 Laboratory Corporation of America Holdings
  • 7.2.1 Laboratory Corporation of America Holdings Business Overview
  • 7.2.2 Laboratory Corporation of America Holdings Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.2.3 Laboratory Corporation of America Holdings Drug and Alcohol Testing Product Introduction
  • 7.2.4 Laboratory Corporation of America Holdings Response to COVID-19 and Related Developments
• 7.3 Abbott
  • 7.3.1 Abbott Business Overview
  • 7.3.2 Abbott Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.3.3 Abbott Drug and Alcohol Testing Product Introduction
  • 7.3.4 Abbott Response to COVID-19 and Related Developments
• 7.4 Roche Diagnostics
  • 7.4.1 Roche Diagnostics Business Overview
  • 7.4.2 Roche Diagnostics Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.4.3 Roche Diagnostics Drug and Alcohol Testing Product Introduction
  • 7.4.4 Roche Diagnostics Response to COVID-19 and Related Developments
• 7.5 Thermo Fisher Scientific
  • 7.5.1 Thermo Fisher Scientific Business Overview
  • 7.5.2 Thermo Fisher Scientific Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.5.3 Thermo Fisher Scientific Drug and Alcohol Testing Product Introduction
  • 7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
• 7.6 Drägerwerk
  • 7.6.1 Drägerwerk Business Overview
  • 7.6.2 Drägerwerk Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.6.3 Drägerwerk Drug and Alcohol Testing Product Introduction
  • 7.6.4 Drägerwerk Response to COVID-19 and Related Developments
• 7.7 Siemens Healthcare
  • 7.7.1 Siemens Healthcare Business Overview
  • 7.7.2 Siemens Healthcare Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.7.3 Siemens Healthcare Drug and Alcohol Testing Product Introduction
  • 7.7.4 Siemens Healthcare Response to COVID-19 and Related Developments
• 7.8 Express Diagnostics
  • 7.8.1 Express Diagnostics Business Overview
  • 7.8.2 Express Diagnostics Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.8.3 Express Diagnostics Drug and Alcohol Testing Product Introduction
  • 7.8.4 Express Diagnostics Response to COVID-19 and Related Developments
• 7.9 Shimadzu
  • 7.9.1 Shimadzu Business Overview
  • 7.9.2 Shimadzu Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.9.3 Shimadzu Drug and Alcohol Testing Product Introduction
  • 7.9.4 Shimadzu Response to COVID-19 and Related Developments
• 7.10 MPD
  • 7.10.1 MPD Business Overview
  • 7.10.2 MPD Drug and Alcohol Testing Quarterly Revenue, 2020
  • 7.10.3 MPD Drug and Alcohol Testing Product Introduction
  • 7.10.4 MPD Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US